Abbonarsi

Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study) - 08/03/25

Doi : 10.1016/j.ahj.2025.02.005 
Yixin Tian, PhD a, , Xin Wang, MD a, , Zhen Hu, PhD a, Xue Yu, MS a, Min Shao, MS b, Chuanxi Zhang, MS b, Dedi Zhang, MS b, Wenping Shan, MS b, Chenye Chang, MS a, Chenda Zhang, MS c, Yuxuan Nie, MS d, Congyi Zheng, PhD a, Xue Cao, PhD a, Xuyan Pei, PhD a, Yujie Zhang, MS a, Nuerguli Tuerdi, MS a, Zengwu Wang, PhD a,
a Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China 
b Department of Epidemiology and Biostatistics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China 
c School of Management, Beijing University of Chinese Medicine, Beijing, China 
d School of Public Health, Bengbu Medical University, Bengbu, China 

#Reprint requests: Zengwu Wang, MD, PhD, Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences. No. 15 (Lin), Fengcunxili, Mentougou District, Beijing 102308, China.Division of Prevention and Community Health, National Center for Cardiovascular Disease, National Clinical Research center of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai HospitalPeking Union Medical College and Chinese Academy of Medical SciencesNo. 15 (Lin), Fengcunxili, Mentougou DistrictBeijing102308China

Highlights

The mHealth-OPEN trial is a workplace-based cardiovascular risk intervention trial.
A PMT-based comprehensive intervention, tailored to individuals, encourages active participation.
Mobile health-based interventions are highly feasible.
10,000 participants were cluster-randomized across 20 workplaces.
The effectiveness of these interventions can be assessed through this ongoing study.

Il testo completo di questo articolo è disponibile in PDF.

ABSTRACT

Background

The substantial workforce and suboptimal cardiovascular health highlights the urgent need for workplace interventions. This ongoing cluster-randomized trial aims to evaluate the effectiveness, feasibility, and acceptability of a mobile health (mHealth) based comprehensive intervention program to improve cardiovascular health among employees.

Methods and results

We conducted a 1-year, 2-arm, parallel-group, cluster-randomized controlled multicenter trial involving 10,000 participants (aged 18-65, including 1,600 participants with high cardiovascular risk) across 20 workplaces. Workplaces were randomly assigned in a 1:1 ratio to either the intervention or control group. We established a mHealth based multifaceted cardiovascular risk management system that enables intelligent management. The intervention groups received a mHealth-based management with primary prevention inventions for all participants and additional cardiovascular risk interventions for participants with high cardiovascular risk via the system. The control groups received usual care. Primary outcomes included percentage changes in hypertension, diabetes, and dyslipidemia control rates among participants with high cardiovascular risk, and percentage changes in the rate of regular physical activity among all the participants, from baseline to 12-month follow-up. Secondary outcomes included changes in blood pressure, glucose, lipid, treatment adherence, behavioral factors, questionnaire scores, and incidence of major cardiovascular events. By now, baseline recruitment has been completed, with comparable characteristics between management and control groups.

Conclusions

This rigorous designed mHealth-based workplace intervention demonstrates potential for nationwide implementation, offering cardiovascular benefits for employees.

Clinical trial registration

www.chictr.org.cn. Identifier: ChiCTR2200066196.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2025  The Author(s). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 284

P. 32-41 - Giugno 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: Rationale and design
  • Donald E. Cutlip, Roxana Mehran, Gheorghe Doros, Vladimir Kaplinskiy, Jane Lee, Luke Zheng, Milan Kausik, Eric Osborn, Ron Waksman
| Articolo seguente Articolo seguente
  • Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)
  • Tatsunori Takahashi, Janet Wei, Ana C. Iribarren, Martha Gulati, Galen Cook-Wiens, Michael D. Nelson, Behzad Sharif, Eileen M. Handberg, R. David Anderson, John Petersen, Daniel S. Berman, Carl J. Pepine, C. Noel Bairey Merz

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.